Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of a novel treatment for patients with chronic kidney disease. Founded in 2013, Tricida is led by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with deep expertise in developing polymers for the treatment of kidney-related diseases.

Tricida, Inc. cordially invites you to attend a virtual program titled “Understanding the Harm Caused by Chronic Metabolic Acidosis”. Meal delivery service will be available for attendees joining the program virtually. Meals are provided solely in conjunction with full attendance at this speaker program.

Click the link to register for one of the five virtual programs:

https://www.annualmeetinghub.com/syneos/anna

(advanced registration required 12 hours before program for meal delivery option)